MedTrace Logo

Monitoring of Systemic or Organ Perfusion for Preterm Infants

NCT03136172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2019-02-27

No results posted yet for this study

Summary

To investigate biomarker reflects systemic or specific organ perfusion well, we are going to the observational comparison study using several hemodynamic monitoring methods in the premature infants. It includes near-infrared spectroscopy (NIRS), pulse oximetry with perfusion index (PI) and pleth variability index (PVI) and functional echocardiography.

Conditions

  • Infant, Premature
  • Hypoperfusion in Newborn
  • Necrotizing Enterocolitis of Newborn
  • Sepsis Newborn
  • Oliguria
  • Hypotension

Interventions

DEVICE

NIRS (near Infra-red spectroscopy)

1. NIRS, INVOS 5100 cerebral/somatic oximeter monitor (Somanetics Corp, Troy, Michigan, USA) 2. Radical-7 pulse oximeter (Masimo Corp, Irvine, CA, USA) 3. Echocardiography (Phillips HD 15 Ultrasound system, CA, USA)

Sponsors & Collaborators

  • Inha University Hospital

    lead OTHER

Eligibility

Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-08
Primary Completion
2018-10-01
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03136172 on ClinicalTrials.gov